speedind ticket

Good response

As part of the Company's periodic monitoring of social media including internet forums and chat rooms, the Company is aware of a very recent increase in postings on certain of these forums including postings on share price movements and relativities between the Company and its technology collaboration partner Isis Pharmaceuticals, Inc (NASDAQ:ISIS) and speculation on the progress of the Company’s Phase II clinical study of ATL1103. The Company's general policy is to offer no specific commentary on individual postings on such forums or chat rooms